|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (Right to Buy) (3) | $ 8.31 | 10/05/2010 | M | 2,512 | 12/05/2003(4) | 12/05/2012 | Common Stock | 2,512 | $ 0 | 4,238 (5) | D | ||||
| Stock Option (Right to Buy) (3) | $ 4.29 | 10/06/2010 | M | 1,290 | 10/26/2002(4) | 10/26/2011 | Common Stock | 1,290 | $ 0 | 2,595 (5) | D | ||||
| Stock Option (Right to Buy) (3) | $ 13.5 | 10/06/2010 | M | 1,000 | 11/28/2004(4) | 11/28/2013 | Common Stock | 1,000 | $ 0 | 10,375 (5) | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| GOLDWYN MARTIN M C/O TASHLIK KREUTZER GOLDWYN & CRANDELL 40 CUTTERMILL ROAD GREAT NECK, NY 11021 |
X | |||
| Martin M. Goldwyn | 10/07/2010 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The shares acquired upon exercise of the options reflected on this line were immediately distributed without consideration to members of Mr. Goldwyn's law firm. |
| (2) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.20 to 21.23, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) of this Form 4. |
| (3) | Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan. |
| (4) | The options became exercisable in four equal annual installments beginning on the first anniversary of the grant date. |
| (5) | Other than the remaining portions of the options to acquire 4,238, 2,595 and 10,375 shares, respectively, reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 61,597 shares of the Company's stock (for total options to acquire an aggegate of 78,805 shares held by the filer). The additional options were granted on various dates, with varying exercise prices and exercisable and expiration dates. |